We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A baby laying down.

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

A ginger haired woman leaning over the arm of a chair.

Scientists Identify Brain Circuit That Suppresses Appetite During Nausea

Immunotherapy attacking a cancer cell.

Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

News

Diabetes Drug May Reverse Alzheimer's and Enters Major Clinical Trial

A commonly prescribed diabetes drug could reverse memory loss and the build-up of plaques on the brain linked to Alzheimer's.

MorphoSys Receives Two Phase 2 Milestone Payments from Janssen

MOR202 in phase 1/2a trial for multiple myeloma.

Midatech Appoints Dr Jim Phillips as Chief Executive Officer

Midatech Ltd. is pleased to announce the appointment of Dr Jim Philips as Chief Executive Officer (CEO).

Columbia Laboratories Acquires Molecular Profiles Ltd.

Transaction expected to further increase earnings and cash flow through diversified revenue stream.

Purdue to Accelerate Drug Discovery, Development

Purdue Center for Drug Discovery adds to Purdue's strengths and the capacity to translate basic research into life-changing treatments.

RSC Unveils its Conference for Lab Innovations 2013

The conference will feature three concurrent strands which explore the latest developments in equipment and best practice for the medicinal, pharmaceutical and chemical industries.

Locating and Explaining ‘Activity Cliffs’ in SAR Datasets

Activity Miner from Cresset is an intuitive SAR interpretation tool, identifying key 3D structural and electrostatic changes that impact molecular activity.

Imaxio Announces the First Human Clinical Trial Using its Pro-Immunogenic Technology IMX313, in Tuberculosis

IMX313 has been administrated for the first time in humans as part of a tuberculosis vaccine phase I clinical trial.

Circassia’s Cat Allergy Treatment Shows Sustained Symptom Improvement

Strong results from phase II clinical trial of Circassia.

Cosmic Factory for Making Building Blocks of Life

Research published in the journal Nature Geoscience details the discovery of a 'cosmic factory' for producing amino acids.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter